MARKET WIRE NEWS

Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy

Source: SeekingAlpha

2026-02-04 02:43:16 ET

Intro

Achieve Life Sciences ( ACHV ) is a pre-commercial, late-stage pharmaceutical company that develops a smoking and vaping cessation therapy. It currently has no sales-generating business, as it is awaiting the FDA’s decision on whether its drug candidate Cytisinicline will be given the green light in about four months in June. If approved for smoking cessation later this year, it would be the first of its kind since 2006 , i.e., exactly 20 years....

Read the full article on Seeking Alpha

For further details see:

Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy
Achieve Life Sciences Inc.

NASDAQ: ACHV

ACHV Trading

2.24% G/L:

$4.345 Last:

185,386 Volume:

$4.38 Open:

mwn-app Ad 300

ACHV Latest News

March 09, 2026 06:33:22 pm
ACHV - Historical Earnings Price Analysis

ACHV Stock Data

$234,761,887
51,636,968
N/A
28
N/A
Biotechnology & Life Sciences
Healthcare
CA
Bothell

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App